ALLR Allarity Therapeutics Inc

USD 0.39 0.00 0
Icon

Allarity Therapeutics Inc (ALLR) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.39

0.00 (0.00)%

USD 2.30M

0.13M

N/A

N/A

Icon

ALLR

Allarity Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 0.39
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.30M

N/A

USD 0.39

Allarity Therapeutics Inc (ALLR) Stock Forecast

N/A

Based on the Allarity Therapeutics Inc stock forecast from 0 analysts, the average analyst target price for Allarity Therapeutics Inc is not available over the next 12 months. Allarity Therapeutics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Allarity Therapeutics Inc is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Allarity Therapeutics Inc’s stock price was USD 0.39. Allarity Therapeutics Inc’s stock price has changed by -3.25% over the past week, -9.93% over the past month and -99.86% over the last year.

No recent analyst target price found for Allarity Therapeutics Inc
No recent average analyst rating found for Allarity Therapeutics Inc

Company Overview Allarity Therapeutics Inc

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase...Read More

https://www.allarity.com

210 Broadway, Cambridge, MA, United States, 02139

0

December

USD

USA

Adjusted Closing Price for Allarity Therapeutics Inc (ALLR)

Loading...

Unadjusted Closing Price for Allarity Therapeutics Inc (ALLR)

Loading...

Share Trading Volume for Allarity Therapeutics Inc Shares

Loading...

Compare Performance of Allarity Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ALLR

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Allarity Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD90.49B 26.38 17.57

ETFs Containing ALLR

Symbol Name ALLR's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Allarity Therapeutics Inc (ALLR) Stock

Stock Target Advisor's fundamental analysis for Allarity Therapeutics Inc's stock is Bearish.

Unfortunately we do not have enough data on ALLR's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ALLR's stock to indicate what its average analyst target is.

ALLR stock's Price/Earning ratio is 0.00. Our analysis grades ALLR stock's Price / Earning ratio at A-. This means that ALLR stock's Price/Earning ratio is above 8.999999999999996% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ALLR may be undervalued for its sector.

The last closing price of ALLR's stock was USD 0.39.

The most recent market capitalization for ALLR is USD 2.30M.

Unfortunately we do not have enough analyst data on ALLR's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Allarity Therapeutics Inc's stock.

As per our most recent records Allarity Therapeutics Inc has 0 Employees.

Allarity Therapeutics Inc's registered address is 210 Broadway, Cambridge, MA, United States, 02139. You can get more information about it from Allarity Therapeutics Inc's website at https://www.allarity.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...